PROFESSIONAL EDITION

The largest community of pharma leaders

Be part of our community by subscribing to our newsletters! Follow the steps below.

1. Subscribe to our Announcement Newsletter. You will receive our news about what do you need to know about our work and the resources available for you. You need to confirm your subscription by email (check your email box and confirm your subscription)

2. Choose your favorite writer. We constantly look for the top minds on the pharmaceutical marketing industry. You can subscribe to their article on their pages and receive every article on your inbox. 

3. Choose the Newsletter that better fits you needs. We recommend the Editor’s pick to receive everything you need to know in one weekly email. 

4. All our newsletters needs to be confirmed by email. After you subscribe on our webpage, you will receive an email asking for your confirmation by clicking a link. Click that link if you want to receive the newsletter. If you don’t receive the email, check your spam box and add our email to your safe sender list. If you address belongs to a company, you may need to forward your confirmation email to your tech department to ask them to add our domain to your company safe sender list. 

You can start here by subscribing to our main Newsletter. Confirm your subscription by clicking CONFIRM on the email you will receive after complete the subscription form.

Don’t forget to check for our other newsletters! Check this page for several options we have for all our users!

NEWSLETTER ANNOUCEMENTS




TPMG FEATURED WRITER NEWSLETTER




2020: looking back at the year when everything changed

A version of this article was previously published on Pharmaphorum. I think it’s fair to say that 2020 will not...

Top 10 Tips for Creating Company Culture in a...

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may...

Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Natalie Yeadon´s Newsletter




2020: looking back at the year when everything changed

A version of this article was previously published on Pharmaphorum. I think it’s fair to say that 2020 will not...

Top 10 Tips for Creating Company Culture in a...

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may...

Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Tommaso Salanitri´s Newsletter




“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

EDITOR´S PICK




Moderna Announces Supply Agreement to Provide 13 Million Doses...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a...

Moderna Announces New Drug Application Submitted to Import and...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that...

GC Pharma Finalises Agreement With Moderna and the Government...

YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (006280.KS) today announced that it will support Moderna and the government of the Republic...

U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line...

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA)...

Yicai: WHO Says Rich Countries Should Fulfill Their Promise...

BRUSSELS--(BUSINESS WIRE)--At present, The World Health Organization (WHO) is working hard to purchase vaccines through its COVAX to ensure...

Iktos Announces Collaboration With Pfizer in AI for Drug...

PARIS--(BUSINESS WIRE)--Iktos announced today the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule...

LOOK WHO IS ON THE MOVE!




Talaris Therapeutics Appoints Mary Kay Fenton as Chief Financial...

BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a late- clinical stage cell therapy company developing therapies with the potential...

Apnimed Strengthens Management Team with Addition of Leading Sleep...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for obstructive sleep apnea and related disorders, today...

CytRx Highlights Orphazyme’s Appointment of New CEO Ahead of...

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development...

Sinclair Research Appoints Sandra Love as Director of Safety...

AUXVASSE, Mo.--(BUSINESS WIRE)--Sinclair Research, a leading provider of nonclinical research services, has named Dr. Sandra Love, PhD as Director...

Diaceutics Appoints Nikita Lynn to Vice President of Finance

PARSIPPANY, N.J.--(BUSINESS WIRE)--Diaceutics PLC, (AIM: DXRX), today announces the appointment of Nikita Lynn to Vice President of Finance. She...

AavantiBio Adds Veteran Life Sciences Executive Douglas J. Swirsky...

BOSTON--(BUSINESS WIRE)--AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, today announced...

INDUSTRY NEWS




EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for...

Covid-19: MedinCell Publishes an Extensive Ivermectin Safety Expert Analysis

MONTPELLIER, France--(BUSINESS WIRE)--MedinCell (Paris:MEDCL): No safety concern is anticipated that would prevent health authorities from assessing the use of Ivermectin...

Genentech’s Actemra Becomes the First Biologic Therapy Approved by...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that...

Merck Begins Tender Offer to Acquire Pandion Therapeutics

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a...

Apollomics, Inc Doses First Patient in Phase 1 Clinical...

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics (Nasdaq: GLYC) today announced that Apollomics has dosed the first patient in China in a Phase...

Amgen to Acquire Five Prime Therapeutics for $1.9 Billion...

THOUSAND OAKS, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage...

REGULATORY AFFAIRS




EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for...

U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular...

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA)...

BeiGene Announces Acceptance of a Supplemental Biologics License Application...

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...

Exicure Granted Orphan Drug Designation by the U.S. Food...

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic...

Xentria Announces Submission of an Investigational New Drug (IND)...

CHICAGO--(BUSINESS WIRE)--Xentria Inc., a biopharmaceutical company focused on developing novel biologics and biosimilars to address unmet clinical needs, today...

Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of...

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...

MEDICAL DEVICES




EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that...

New Alcon Innovations in Intraocular Lenses, Digital Health Solutions...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, will highlight a...

Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development...

BOSTON & LONDON--(BUSINESS WIRE)--Synthace Ltd and Ipsen, a global biopharmaceutical company focused on innovation and specialty care, have partnered...

World’s Leading Home Improvement Retailer Battling COVID-19 Impact with...

MIDDLETOWN, Conn.--(BUSINESS WIRE)--Reality Interactive, a leading retail technology design firm and digital agency in Middletown, Connecticut, announced the launch...

PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency...

Optomec Delivers 3D Electronics Printer for Medical Device Production

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Optomec has delivered a new industrialized 3D Printed Electronics system to a major US healthcare manufacturer, where...

HOSPITAL NEWS




Applied DNA and Evvivax Initiate Phase I of Clinical...

STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction...

Altasciences Performs Phase I Studies for FDA Approval of...

LAVAL, Quebec--(BUSINESS WIRE)--Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early...

Abzena Selected by Immunome to Develop and Manufacture Antibody...

EXTON, Pa. & SAN DIEGO--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell...

Bristol Myers Squibb and The Rockefeller University Announce License...

NEW YORK--(BUSINESS WIRE)--BMS & The Rockefeller University Announce License Agreement for SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment...

PhysIQ Saw Significant Adoption of Their AI Technology in...

CHICAGO--(BUSINESS WIRE)--PhysIQ, Inc. will mark 2020 as a very important year-to-date for the leader in furthering acceptance and adoption...

EUSA Pharma and BeiGene Announce Acceptance of a Biologics...

January 25, 2021 07:00 AM Eastern Standard Time HEMEL HEMPSTEAD, England & BEIJING, China & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EUSA Pharma (UK)...

CLINICAL TRIALS




Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a...

MIAMI & KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics,...

Can-Fite Enrolls First Patient in Phase II COVID-19 Study...

PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small...

Ridgeback Biotherapeutics Announces Publication of Phase 1 Double-Blind, Placebo-Controlled...

MIAMI--(BUSINESS WIRE)--Ridgeback Biotherapeutics, LP today announced the publication of results from its first-in-human Phase 1 study of molnupiravir (EIDD-2801/MK-4482)...

New Research Reveals More CROs Taking Action to Meet...

PLEASANTON, Calif.--(BUSINESS WIRE)--Contract research organizations (CROs) are making significant advancements to modernize and speed clinical trials, according to the...

Forendo Pharma Successfully Completes Phase 1 Studies of FOR-6219...

TURKU, Finland--(BUSINESS WIRE)--Forendo Pharma, a clinical-stage drug development company focusing on novel treatments in women’s health, today announced the...

Azura Ophthalmics Announces Positive Topline Results From Phase 2...

TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction...